0000950170-24-084952.txt : 20240719
0000950170-24-084952.hdr.sgml : 20240719
20240719163511
ACCESSION NUMBER: 0000950170-24-084952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240717
FILED AS OF DATE: 20240719
DATE AS OF CHANGE: 20240719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamothe Jeffrey G.
CENTRAL INDEX KEY: 0001679967
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 241128163
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
ownership.xml
4
X0508
4
2024-07-17
0001671584
Aptevo Therapeutics Inc.
APVO
0001679967
Lamothe Jeffrey G.
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
false
true
false
false
EVP, COO
false
Restricted Stock Unit
2024-07-17
4
A
false
12825
0
A
Common Stock
12825
12825
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
The RSUs vest in three approximately equal annual installments beginning on July 17, 2025.
/s/ SoYoung Kwon, Attorney-In-Fact
2024-07-19